Lithiated gold nanoparticles as promising therapy for Alzheimer's disease
Collectively, a-LiG-AuNPs offer a promising method for brain-specific Li+ delivery, potentially beneficial for treating GSK-3β-dependent neurological diseases such as AD, while avoiding the Li+ side effects.
Authors
- Alfonso Grassi (ORCID: https://orcid.org/0000-0002-2664-3114)
- Roberto Piacentini (ORCID: https://orcid.org/0000-0003-4215-1643)
- Martina Albini (ORCID: https://orcid.org/0000-0001-5671-2742)
- Antonio Buonerba (ORCID: https://orcid.org/0000-0003-1101-3248)
- Beatrice Cannata (ORCID: https://orcid.org/0009-0000-4158-0062)
- Gulia Puliatti
- Claudio Grassi
- Laura Sposito
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Salerno (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_097598
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00